Adult Vaccines Market Overview: Navigating the Landscape of Preventive Medicine

 Adult vaccines are immunization shots given to individuals above the age of 18 to protect from various infectious diseases. They help enhance immunity against viruses and bacteria that can cause health issues like pneumonia, shingles, hepatitis etc. in adults. With growing knowledge about the importance of adult immunization in preventing illnesses, the demand for vaccines such as pneumococcal vaccine, tetanus-diphtheria-acellular pertussis vaccine and herpes zoster vaccine is rising. The global Adult Vaccines Market is estimated to be valued at US$ 16,790.11 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving the adult vaccines market is the rising awareness about adult vaccination. Public health organizations across the world are undertaking various awareness programs to educate adults regarding the need for booster doses. They are emphasizing that immunity from diseases contracted during childhood can reduce over time and booster shots are required to prevent future illness. This is increasing the understanding levels about vaccination among the adult population. As per estimates, only 30-40% of adults in developed nations receive recommended immunizations. With continuous campaigns, this percentage is projected to improve over the coming years and positively influence the demand for adult vaccines.

Segment Analysis
The global adult vaccines market is dominated by seven-valent pneumococcal conjugate vaccine sub segment as it protects against seven serotypes responsible for a major burden of pneumococcal disease globally. This sub segment holds a market share of over 30% as of 2024 owing to rising incidence of pneumococcal diseases and increasing emphasis on immunization programs globally.

Key Takeaways
The global adult vaccines market is expected to witness high growth over the forecast period owing to rising incidence of infectious diseases and increasing emphasis on immunization by healthcare agencies worldwide.

Regional analysis comprises: North America currently dominates the global adult vaccines market and is expected to continue its dominance over the forecast period. Higher awareness regarding vaccination, stringent immunization schedules, and easy access to healthcare services are some key factors supporting the growth of adult vaccines market in the region.
Asia Pacific is expected to be the fastest growing region in the global adult vaccines market owing to growing healthcare expenditure, rising penetration of healthcare insurance, and rapid economic development in countries such as China and India. Countries in the region are also focusing on reducing disease burden through national immunization programs which is further expected to drive the adult vaccines market growth in Asia Pacific.

Key players operating in the adult vaccines market are GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc. GlaxoSmithKline Plc is one of the leading players owing to its robust vaccine portfolio such as Boostrix and Cervarix for immunization against tetanus, diphtheria, and pertussis. Merck & Co. also offers various adult vaccines for hepatitis, shingles, pneumonia and herpes zoster through its subsidiary MSD. Players are focusing on expanding their geographic presence and enhancing their research capabilities for developing novel vaccines to strengthen their market position.

Adult Vaccines Market Growth: Strategies for Immunization Success

 

Market Overview:

Adult vaccines refer to vaccines recommended for adults aged 19 years and older to protect against diseases and conditions. They help prevent illnesses like influenza, pneumonia, shingles, and tetanus among older adults.

The  global adult vaccines market is estimated to be valued at US$ 16,790.11 million in 2022 and is expected to exhibit a CAGR of 7.1% during the forecast period (2022-2030).

Market Dynamics:

The adult vaccines market is expected to witness significant growth over the forecast period owing to increasing demand for preventive healthcare and awareness regarding vaccine-preventable diseases. According to Centers for Disease Control and Prevention (CDC), adults require some vaccines to stay healthy throughout their lives. They need recommended vaccines to protect against diseases they may not have been vaccinated for as children, like hepatitis A and B, as well as diseases that have greater impact in adulthood, like shingles. Additionally, evolving demographics like aging population are increasingly susceptible to infections and diseases, hence require immunization against them. For example, pneumococcal pneumonia is responsible for significant morbidity and mortality among older adults and adults with certain underlying medical conditions.

Increasing Incidences of Chronic and Infectious Diseases

The incidences of infectious diseases and chronic illnesses such as hepatitis, shingles, pneumonia and meningococcal diseases are rising globally due to aging population, lifestyle changes and urbanization. Diseases such as hepatitis, pneumococcal diseases and human papilloma virus (HPV) pose a significant threat to elderly people. As per CDC reports, elderly people are more susceptible to contracting infections. According to WHO, by 2050 around 2 billion people will be aged 60 years and above. Growing aging population is driving the demand for adult vaccines to fight against chronic and infectious diseases. Vaccines help boost immunity and lower healthcare costs associated with the treatment of such diseases.

Rising Awareness about Vaccine Preventable Diseases

In the past few years, awareness about potentially life-threatening adult vaccine preventable diseases has increased significantly. Various government and non-government organizations conduct awareness campaigns to educate people about the importance and benefits of adult immunization. Healthcare providers are also playing a vital role in recommending adult vaccination schedules to their patients. Introduction of social media and digital platforms has further enhanced access to health information. Increasing awareness is motivating more adults to get recommended vaccinations and boosting their immunity against infections.

Explorer more information on this topic, Please visit @  https://www.coherentmarketinsights.com/market-insight/adult-vaccines-market-1091 

High Cost of Vaccine Development and Manufacturing

Developing and manufacturing vaccines involves huge financial investments and takes several years. Clinical trials and approval procedures conforming to regulatory guidelines make vaccine development a highly regulated and lengthy process. Stringent production practices and quality standards significantly increase manufacturing costs. Maintaining cold chain during storage and transportation of vaccines from manufacturing facilities to end users also adds to the overall costs. High R&D and manufacturing costs are passed on to the consumers making vaccines less affordable. This acts as a major barrier in widespread adoption of adult vaccination programs especially in low and middle income countries.

Increasing Healthcare Expenditure on Treatment of Vaccine Preventable Diseases

Treatment and management of infectious diseases puts a heavy burden on already strained healthcare budgets. As per WHO, vaccine preventable diseases account for hundreds of billions of dollars in direct and indirect costs annually worldwide. Hospitalization, missed work and loss of productivity due to such diseases contributes significantly to the overall economic burden. Since elderly population is more vulnerable, expenditure on their treatment becomes even more expensive. In the long run, investment in adult vaccination programs proves to be far more cost effective compared to life time treatment and care of vaccine preventable illnesses. This presents a huge opportunity for the adult vaccines market to grow further.

Rapid Uptake of Combination Vaccines

Pharmaceutical companies are increasingly focusing on development of safer and more effective combination vaccines targeting multiple diseases with a single shot. Combination vaccines have merits such as fewer doctor visits, reduced pain of injection, greater patient compliance and lowered administration costs. Their introduction has boosted immunization rates substantially. As per research reports, sales of combination vaccines are expected to surge in the coming years owing to higher efficacy and patient convenience. Transition from single antigen to multivalent vaccines is viewed as a major trend in the adult vaccines industry. Combination vaccines offering protection against pneumococcal, meningococcal and zoster diseases will dominate the market.